Department of Epidemiology, Harvard T.H. Chan School of Public Health, 677 Huntington Ave, Boston, MA 02115, United States.
Population Sciences Branch, Division of Intramural Research, National Heart, Lung and Blood Institute, 31 Center Drive, Bethesda, MD 20892, United States.
Hum Mol Genet. 2024 Sep 3;33(18):1584-1591. doi: 10.1093/hmg/ddae097.
Venous thromboembolism (VTE) is a significant contributor to morbidity and mortality, with large disparities in incidence rates between Black and White Americans. Polygenic risk scores (PRSs) limited to variants discovered in genome-wide association studies in European-ancestry samples can identify European-ancestry individuals at high risk of VTE. However, there is limited evidence on whether high-dimensional PRS constructed using more sophisticated methods and more diverse training data can enhance the predictive ability and their utility across diverse populations. We developed PRSs for VTE using summary statistics from the International Network against Venous Thrombosis (INVENT) consortium genome-wide association studies meta-analyses of European- (71 771 cases and 1 059 740 controls) and African-ancestry samples (7482 cases and 129 975 controls). We used LDpred2 and PRS-CSx to construct ancestry-specific and multi-ancestry PRSs and evaluated their performance in an independent European- (6781 cases and 103 016 controls) and African-ancestry sample (1385 cases and 12 569 controls). Multi-ancestry PRSs with weights tuned in European-ancestry samples slightly outperformed ancestry-specific PRSs in European-ancestry test samples (e.g. the area under the receiver operating curve [AUC] was 0.609 for PRS-CSx_combinedEUR and 0.608 for PRS-CSxEUR [P = 0.00029]). Multi-ancestry PRSs with weights tuned in African-ancestry samples also outperformed ancestry-specific PRSs in African-ancestry test samples (PRS-CSxAFR: AUC = 0.58, PRS-CSx_combined AFR: AUC = 0.59), although this difference was not statistically significant (P = 0.34). The highest fifth percentile of the best-performing PRS was associated with 1.9-fold and 1.68-fold increased risk for VTE among European- and African-ancestry subjects, respectively, relative to those in the middle stratum. These findings suggest that the multi-ancestry PRS might be used to improve performance across diverse populations to identify individuals at highest risk for VTE.
静脉血栓栓塞症(VTE)是发病率和死亡率的重要因素,黑人和白人之间的发病率存在很大差异。基于全基因组关联研究中发现的变体的多基因风险评分(PRS)可识别出 VTE 风险较高的欧洲血统个体。然而,关于使用更复杂的方法和更多样化的训练数据构建高维 PRS 是否可以提高预测能力及其在不同人群中的实用性,证据有限。我们使用国际静脉血栓形成联盟(INVENT)全基因组关联研究荟萃分析的汇总统计数据,为 VTE 开发了 PRS,该研究包括欧洲血统(71771 例病例和 1059740 例对照)和非洲血统样本(7482 例病例和 129975 例对照)。我们使用 LDpred2 和 PRS-CSx 构建了特定于血统和多血统的 PRS,并在独立的欧洲血统(6781 例病例和 103016 例对照)和非洲血统样本(1385 例病例和 12569 例对照)中评估了它们的性能。在欧洲血统的测试样本中,经过调整权重的多血统 PRS 略优于特定于血统的 PRS(例如,PRS-CSx_combinedEUR 的接收器操作曲线下面积(AUC)为 0.609,PRS-CSxEUR 的 AUC 为 0.608[P=0.00029])。在非洲血统的测试样本中,经过调整权重的多血统 PRS 也优于特定于血统的 PRS(PRS-CSxAFR:AUC=0.58,PRS-CSx_combined AFR:AUC=0.59),尽管这种差异没有统计学意义(P=0.34)。表现最佳的 PRS 的最高五分位数与欧洲和非洲血统的受试者相比,VTE 的风险分别增加了 1.9 倍和 1.68 倍,而处于中间层的受试者则处于中间层。这些发现表明,多血统 PRS 可能用于改善不同人群的性能,以识别 VTE 风险最高的个体。